losartan "jubilant" 50 mg filmovertrukne tabletter
jubilant pharmaceuticals nv - losartankalium - filmovertrukne tabletter - 50 mg
meloxicam "bluefish" 15 mg tabletter
bluefish pharmaceuticals ab - meloxicam - tabletter - 15 mg
pantoprazol "bluefish" 20 mg enterotabletter
bluefish pharmaceuticals ab - pantoprazolnatriumsesquihydrat - enterotabletter - 20 mg
pramipexol "bluefish" 0,18 mg tabletter
bluefish pharmaceuticals ab - pramipexoldihydrochloridmonohydrat - tabletter - 0,18 mg
pramipexol "bluefish" 0,35 mg tabletter
bluefish pharmaceuticals ab - pramipexoldihydrochloridmonohydrat - tabletter - 0,35 mg
pramipexol "bluefish" 0,7 mg tabletter
bluefish pharmaceuticals ab - pramipexoldihydrochloridmonohydrat - tabletter - 0,7 mg
xeomin 100 enheder pulver til injektionsvæske, opløsning
merz pharmaceuticals gmbh - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 100 enheder
xeomin 200 enheder pulver til injektionsvæske, opløsning
merz pharmaceuticals gmbh - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 200 enheder
xeomin 50 enheder pulver til injektionsvæske, opløsning
merz pharmaceuticals gmbh - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 50 enheder
thiotepa riemser
esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.